191 related articles for article (PubMed ID: 2891137)
1. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Reinhard JF; Diliberto EJ; Viveros OH; Daniels AJ
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8160-4. PubMed ID: 2891137
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cellular transport, subcellular distribution, and secretion of the neurotoxicant 1-methyl-4-phenylpyridinium in bovine adrenomedullary cell cultures.
Reinhard JF; Diliberto EJ; Daniels AJ
J Neurochem; 1989 Apr; 52(4):1253-9. PubMed ID: 2926400
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures.
Reinhard JF; Carmichael SW; Daniels AJ
J Neurochem; 1990 Jul; 55(1):311-20. PubMed ID: 1972391
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine depletion and accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP(+)) in adrenal medullary chromaffin cells.
Wilson SP; Beeler JF
Neurochem Int; 1988; 13(3):333-43. PubMed ID: 19651089
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules.
Darchen F; Scherman D; Desnos C; Henry JP
Biochem Pharmacol; 1988 Nov; 37(22):4381-7. PubMed ID: 3264161
[TBL] [Abstract][Full Text] [Related]
6. Subcellular compartmentation of 2'methyl MPP+ can explain differences in toxicity to adrenal chromaffin cells.
Reinhard JF; Daniels AJ
Ann N Y Acad Sci; 1992 May; 648():323-5. PubMed ID: 1353333
[No Abstract] [Full Text] [Related]
7. Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization.
Reinhard JF; Daniels AJ; Painter GR
Biochem Biophys Res Commun; 1990 May; 168(3):1143-8. PubMed ID: 2346481
[TBL] [Abstract][Full Text] [Related]
8. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
Reinhard JF; Daniels AJ; Viveros OH
Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
[TBL] [Abstract][Full Text] [Related]
9. Effects of reserpine and tetrabenazine on catecholamine and ATP storage in cultured bovine adrenal medullary chromaffin cells.
Caughey B; Kirshner N
J Neurochem; 1987 Aug; 49(2):563-73. PubMed ID: 3598586
[TBL] [Abstract][Full Text] [Related]
10. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
Algeri S; Ambrosio S; Garofalo P; Gerli P
Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
[TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 1-methyl-4-phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: a 13C and 31P NMR study.
Daniels AJ; Reinhard JF; Painter GR
Biochem Biophys Res Commun; 1988 Nov; 156(3):1243-9. PubMed ID: 3263856
[TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-4-phenylpyridinium is a substrate of the vesicular monoamine uptake system of chromaffin granules.
Scherman D; Darchen F; Desnos C; Henry JP
Eur J Pharmacol; 1988 Feb; 146(2-3):359-60. PubMed ID: 3259507
[No Abstract] [Full Text] [Related]
14. The interaction of 1-methyl-4-phenylpyridinium (MPP+) with bovine adrenal medulla chromaffin vesicle ghosts.
Farmer MK; Tipton KF
Biochem Soc Trans; 1996 Feb; 24(1):60S. PubMed ID: 8674735
[No Abstract] [Full Text] [Related]
15. Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines.
Martel F; Martins MJ; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):305-11. PubMed ID: 8878060
[TBL] [Abstract][Full Text] [Related]
16. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
17. Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets.
Cesura AM; Ritter A; Picotti GB; Da Prada M
J Neurochem; 1987 Jul; 49(1):138-45. PubMed ID: 3495635
[TBL] [Abstract][Full Text] [Related]
18. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.
Moriyama Y; Amakatsu K; Futai M
Arch Biochem Biophys; 1993 Sep; 305(2):271-7. PubMed ID: 8373164
[TBL] [Abstract][Full Text] [Related]
19. The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin.
Ribeiro L; Martel F; Azevedo I
Regul Pept; 2006 Dec; 137(3):107-13. PubMed ID: 16846655
[TBL] [Abstract][Full Text] [Related]
20. Loss and Ca(2+)-dependent retention of scinderin in digitonin-permeabilized chromaffin cells: correlation with Ca(2+)-evoked catecholamine release.
Vitale ML; RodrÃguez Del Castillo A; Trifaró JM
J Neurochem; 1992 Nov; 59(5):1717-28. PubMed ID: 1402916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
